These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6806660)

  • 21. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a hemoglobin substitute in the anemic Jehovah's Witness patient.
    Marelli TR
    Crit Care Nurse; 1994 Feb; 14(1):31-8. PubMed ID: 8194324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Success in the radical resection of esophageal cancer with artificial blood infusion: case report.
    Mitsuno T; Kawa Y; Kita A; Kohno N
    Int Surg; 1981; 66(4):355-8. PubMed ID: 7345051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 26. Current perspectives on blood substitutes.
    Gould SA; Moss G
    Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573
    [No Abstract]   [Full Text] [Related]  

  • 27. Present trends in fluorocarbon-based blood substitutes.
    Riess JG
    Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 29. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternatives to allogeneic blood transfusions.
    Mulier M
    Acta Anaesthesiol Belg; 2002; 53(2):119-24. PubMed ID: 12146099
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of cerebral ischemia with Fluosol.
    Peerless SJ; Nakamura R; Rodriguez-Salazar A; Hunter IG
    Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Will Japanese white blood be coursing through our veins? A revolution: the first synthetic blood will soon be commercialized].
    Lecuyer G
    Servir; 1989; 37(5):270-3. PubMed ID: 2516646
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in cerebral and muscular gas tension during normo-volemic hemodilution with Fluosol-DA in dogs (author's transl)].
    Kosugi I; Kitagaki T; Okada K; Matsushima K
    Kokyu To Junkan; 1980 Apr; 28(4):389-94. PubMed ID: 7403706
    [No Abstract]   [Full Text] [Related]  

  • 34. Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier.
    Keipert PE; Faithfull NS; Roth DJ; Bradley JD; Batra S; Jochelson P; Flaim KE
    Adv Exp Med Biol; 1996; 388():603-9. PubMed ID: 8798865
    [No Abstract]   [Full Text] [Related]  

  • 35. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood substitutes: where do we stand with the fluorocarbon approach?
    Riess JG
    Curr Surg; 1988; 45(5):365-70. PubMed ID: 3073041
    [No Abstract]   [Full Text] [Related]  

  • 37. PFC as blood substitutes--an overview.
    Geyer RP
    Prog Clin Biol Res; 1983; 122():157-68. PubMed ID: 6878357
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood substitutes].
    Tomoda H
    Nihon Rinsho; 1983 Dec; 41(12):2803-9. PubMed ID: 6371303
    [No Abstract]   [Full Text] [Related]  

  • 39. [Perftoran--blood substitute with oxygen transport function].
    Golubev AM
    Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of FDA 20 infusion on endocrine function in surgical patients (author's transl)].
    Matsuki A; Tanioka F; Miyahara T; Nagao H; Kudo T; Oyama T
    Masui; 1982 Mar; 31(3):235-9. PubMed ID: 7109218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.